These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31255926)

  • 1. Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
    Zaraei SO; Abduelkarem AR; Anbar HS; Kobeissi S; Mohammad M; Ossama A; El-Gamal MI
    Eur J Med Chem; 2019 Oct; 179():257-271. PubMed ID: 31255926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfamates and their therapeutic potential.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Med Res Rev; 2005 Mar; 25(2):186-228. PubMed ID: 15478125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure and bioactivity of primary sulfamate-containing natural products.
    Mujumdar P; Bua S; Supuran CT; Peat TS; Poulsen SA
    Bioorg Med Chem Lett; 2018 Sep; 28(17):3009-3013. PubMed ID: 29685656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel sulfamate derivatives of menthol: Synthesis, characterization, and cholinesterases and carbonic anhydrase enzymes inhibition properties.
    Daryadel S; Atmaca U; Taslimi P; Gülçin İ; Çelik M
    Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800209. PubMed ID: 30255953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-sulfamates target the essential glycerol-phosphate acyltransferase (PlsY) in Gram-positive bacteria.
    Cherian PT; Yao J; Leonardi R; Maddox MM; Luna VA; Rock CO; Lee RE
    Bioorg Med Chem; 2012 Aug; 20(16):4985-94. PubMed ID: 22795901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
    Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2003 May; 46(11):2197-204. PubMed ID: 12747791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of urease inhibitory effect of sulfamate derivatives: Biological and computational studies.
    Zaib S; Tayyab Younas M; Zaraei SO; Khan I; Anbar HS; El-Gamal MI
    Bioorg Chem; 2022 Feb; 119():105545. PubMed ID: 34915286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives.
    De Monte C; Carradori S; Secci D; D'Ascenzio M; Vullo D; Ceruso M; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():240-6. PubMed ID: 25019479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.
    Temperini C; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4282-6. PubMed ID: 18640037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
    Shah R; Singh J; Singh D; Jaggi AS; Singh N
    Eur J Med Chem; 2016 May; 114():170-90. PubMed ID: 26974384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
    Ciobanu LC; Poirier D
    J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
    Casini A; Antel J; Abbate F; Scozzafava A; David S; Waldeck H; Schäfer S; Supuran CT
    Bioorg Med Chem Lett; 2003 Mar; 13(5):841-5. PubMed ID: 12617904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: aliphatic N-phosphorylated sulfamates--a novel zinc-anchoring group leading to nanomolar inhibitors.
    Bonnac L; Innocenti A; Winum JY; Casini A; Montero JL; Scozzafava A; Barragan V; Supuran CT
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):275-8. PubMed ID: 15500000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
    Joseph P; Ouahrani-Bettache S; Montero JL; Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Winum JY; Köhler S; Supuran CT
    Bioorg Med Chem; 2011 Feb; 19(3):1172-8. PubMed ID: 21251841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates.
    Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2003 Dec; 46(25):5471-7. PubMed ID: 14640555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
    Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024).
    Mustafa EM; Shahin AI; Alrashed AS; Bahaaddin AH; Alajmi AA; Hashem O; Anbar HS; El-Gamal MI
    Arch Pharm (Weinheim); 2024 Jun; ():e2400331. PubMed ID: 38943437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promiscuity of carbonic anhydrase II. Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors.
    Lopez M; Vu H; Wang CK; Wolf MG; Groenhof G; Innocenti A; Supuran CT; Poulsen SA
    J Am Chem Soc; 2011 Nov; 133(45):18452-62. PubMed ID: 21958118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides.
    Shank RP; McComsey DF; Smith-Swintosky VL; Maryanoff BE
    Chem Biol Drug Des; 2006 Aug; 68(2):113-9. PubMed ID: 16999776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.
    Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT
    Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.